CN103450225B - The preparation method of cefoxitin sodium - Google Patents
The preparation method of cefoxitin sodium Download PDFInfo
- Publication number
- CN103450225B CN103450225B CN201310369951.1A CN201310369951A CN103450225B CN 103450225 B CN103450225 B CN 103450225B CN 201310369951 A CN201310369951 A CN 201310369951A CN 103450225 B CN103450225 B CN 103450225B
- Authority
- CN
- China
- Prior art keywords
- add
- sodium
- acid
- cefoxitin
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- GNWUOVJNSFPWDD-XMZRARIVSA-M Cefoxitin sodium Chemical compound [Na+].N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)CC1=CC=CS1 GNWUOVJNSFPWDD-XMZRARIVSA-M 0.000 title claims abstract description 50
- 229960003016 cefoxitin sodium Drugs 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 41
- 229960002682 cefoxitin Drugs 0.000 claims abstract description 21
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical group ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 claims abstract description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 45
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 28
- 238000003756 stirring Methods 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 16
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 14
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- 238000005406 washing Methods 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- 239000012065 filter cake Substances 0.000 claims description 9
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 8
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 8
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 238000001291 vacuum drying Methods 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 7
- 238000010792 warming Methods 0.000 claims description 7
- 239000013078 crystal Substances 0.000 claims description 6
- 239000012044 organic layer Substances 0.000 claims description 6
- 239000000376 reactant Substances 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 6
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical group CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 4
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 4
- 239000001540 sodium lactate Substances 0.000 claims description 4
- 235000011088 sodium lactate Nutrition 0.000 claims description 4
- 229940005581 sodium lactate Drugs 0.000 claims description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 235000010265 sodium sulphite Nutrition 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 11
- 230000007062 hydrolysis Effects 0.000 abstract description 10
- 238000000034 method Methods 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 abstract description 6
- -1 methoxyl group Chemical group 0.000 abstract description 5
- 125000001246 bromo group Chemical group Br* 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract description 2
- 125000002252 acyl group Chemical group 0.000 abstract description 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 2
- 238000006073 displacement reaction Methods 0.000 abstract description 2
- 229910052731 fluorine Inorganic materials 0.000 abstract description 2
- 239000011737 fluorine Substances 0.000 abstract description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 2
- 238000009434 installation Methods 0.000 abstract description 2
- 230000000269 nucleophilic effect Effects 0.000 abstract description 2
- 238000004064 recycling Methods 0.000 abstract description 2
- 230000031709 bromination Effects 0.000 abstract 1
- 238000005893 bromination reaction Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 14
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 12
- 239000000126 substance Substances 0.000 description 11
- 239000002994 raw material Substances 0.000 description 8
- 238000006467 substitution reaction Methods 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 6
- 239000013067 intermediate product Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 159000000000 sodium salts Chemical class 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229930186147 Cephalosporin Natural products 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000005917 acylation reaction Methods 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- QGXKMJVEULWQSB-VWNXMTODSA-N benzhydryl (6r,7s)-7-amino-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound S([C@@H]1[C@@](C(N1C=1C(=O)OC(C=2C=CC=CC=2)C=2C=CC=CC=2)=O)(N)OC)CC=1CSC1=NN=NN1C QGXKMJVEULWQSB-VWNXMTODSA-N 0.000 description 3
- 229940124587 cephalosporin Drugs 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 150000003951 lactams Chemical class 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000000967 suction filtration Methods 0.000 description 3
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229960000603 cefalotin Drugs 0.000 description 2
- VUFGUVLLDPOSBC-XRZFDKQNSA-M cephalothin sodium Chemical compound [Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C([O-])=O)C(=O)CC1=CC=CS1 VUFGUVLLDPOSBC-XRZFDKQNSA-M 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 235000019800 disodium phosphate Nutrition 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- JILPJDVXYVTZDQ-UHFFFAOYSA-N lithium methoxide Chemical compound [Li+].[O-]C JILPJDVXYVTZDQ-UHFFFAOYSA-N 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000036632 reaction speed Effects 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- BUXTXUBQAKIQKS-UHFFFAOYSA-N sulfuryl diisocyanate Chemical compound O=C=NS(=O)(=O)N=C=O BUXTXUBQAKIQKS-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- UCKZMPLVLCKKMO-LHLIQPBNSA-N cephamycin Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](C)[C@]21OC UCKZMPLVLCKKMO-LHLIQPBNSA-N 0.000 description 1
- 150000003946 cyclohexylamines Chemical class 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BUBWTSJXUHKBBX-UHFFFAOYSA-N ethyl acetate;sodium Chemical compound [Na].CCOC(C)=O BUBWTSJXUHKBBX-UHFFFAOYSA-N 0.000 description 1
- 125000005909 ethyl alcohol group Chemical group 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000004260 plant-type cell wall biogenesis Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000011003 system suitability test Methods 0.000 description 1
Landscapes
- Cephalosporin Compounds (AREA)
Abstract
The preparation method who the invention discloses a kind of cefoxitin sodium, comprising: (1) adopts NBS reagent by as 7 of the main core of cefoxitin brominations, forms brominated compound; Recycling methoxyl group is to the bromine atoms nucleophilic displacement of fluorine of 5, production intermediate compound IV; 3 acyl groups that are hydrolyzed of step (2) intermediate compound IV obtain intermediate V; Step (3) is utilized the hydrogen atom on chlorosulphonyl isocyanate substituted hydroxy, and then hydrolysis, has both obtained cefoxitin sodium. The method technique is simple, and product yield is high, and purity is high, and reaction selectivity is high, and production need not any special installation, is applicable to suitability for industrialized production.
Description
Technical field
The present invention relates to material medicine preparation field, be specifically related to a kind of preparation side of cefoxitin sodiumMethod.
Background technology
Cefoxitin sodium, chemical name is: (6R, 7S)-3-carbamyl yloxymethyl-7-methoxyl group-8-oxo-7-[2 (2-thiophene, acetamido)] assorted nitrogen dicyclo-[4,2, the 0]-Xin of-5-thia-1--2-alkene-formic acid sodium salt, molecular formula: C16H16N3NaO7S2, molecular weight: 449.43, chemical structural formulaAs follows:
Cefoxitin sodium, is developed by Merk company of the U.S., and listing in 1994, is to be produced by streptomyceteCephamycin C through the semi-synthetic class new antibiotic making. Cefoxitin sodium is due to canAnti-bacteria Cell wall synthesis and kill bacteria, and due to structural particularity, bacterium is producedBeta-lactamase stable, there is huge market potential.
At present, the synthetic method of cefoxitin sodium, has a lot of documents and patent report. Its synthetic routeMainly contain 3: (1), taking cephamycin as raw material, is first modified the amino on its carboxylic acid side chain,Then its four-membered ring is modified, this route exist technique loaded down with trivial details, need noble metal catalyst etc.Shortcoming, therefore never meet the demand of industrialized production; (2) with cephalothin acid or sodium saltFor raw material, first modify the C of 7-amino-cephalosporanic acid (7-ACA)3Side chain on position, then modifiesC7Bit amino side chain or taking cephalothin acid or sodium salt as raw material, first modifies the C of 7-ACA7Position ammoniaBase side chain, then modifies C3Side chain on position, although this route raw material is cheap and easy to get, reactionIn process, need to use molecular sieve and reactions steps generally all longer, therefore also never can industrializationProduce; (3) taking methoxyl group cephalosporin (7-MAC) as raw material, first modify the C of 7-MAC7Bit amino side chain, then modifies the side chain on C3 position, although this route synthesis step simplify,That 7-MAC is expensive and be difficult to obtain, therefore be not also applied to industrialized production always.
Publication number is that CN101007812A Chinese patent application discloses antibacterial drugs cefoxitinPreparation method, taking 7a-methoxyl group-7 beta-amino-cephalosporanic acid (7-MAC) as raw material, through 2-thiopheneFen acetyl glycosylation reaction, hydrolysis and carbamylization reaction, obtain Cefoxitin (I), the partyMethod has improved the productive rate of Cefoxitin and sodium salt thereof effectively, has avoided harsh reaction condition, savesProduction cost.
Publication number is to disclose a kind of cefoxitin sodium in the Chinese patent application of CN101235045APreparation method, taking cefoxitin as raw material, carry out carbamyl, 3 Imported Ammonia methanoyl firstBase, generates intermediate product; Intermediate product and methyl alcohol-lithium methoxide solution reaction, introduce oxygen methyl for 7,Generate cefoxitin acid; Cefoxitin acid is dissolved in organic solvent, add sodium salt ethyl acetate (orMethyl alcohol) solution, suction filtration, drying under reduced pressure, obtains cefoxitin sodium.
Summary of the invention
The invention provides a kind of preparation method of cefoxitin sodium, this preparation method's step is simple and formerMaterial be easy to get and react selectively good, yield and the purity of product are high.
A preparation method for cefoxitin sodium, comprises the steps:
(1) in organic solvent, under the condition that methanesulfonic acid exists, cefoxitin (II) and NBS(N-bromo-succinimide) and sodium methoxide carry out substitution reaction and obtain the centre of methoxy substitution successivelyProduct, carries out salify with cyclohexylamine after this intermediate product acidifying and obtains 7-α-methoxyl group-7-[(2-thienyl)Acetylamino]-4-cephalosporanic acid cyclohexylamine salt (IV);
(2) 7-α-methoxyl group-7-[(2-thienyl step (1) being obtained) acetylamino]-4-cephaloAlkanoic acid cyclohexylamine salt (IV) is hydrolyzed to react and obtains hydrolysate under alkali condition, and this hydrolysis is producedThing acidified after and acetic acid benzyl star salify obtain 3-hydroxyl first-7-α-[(2-thienyl) acetylamino]-4-Cephalosporanic acid acetic acid benzyl star salt (V);
(3) 3-hydroxyl first-7-α-[(2-thienyl) acetylamino]-4-cephalo step (2) being obtainedAlkanoic acid acetic acid benzyl star salt (V) and chlorosulphonyl isocyanate carry out acylation reaction, after reacting completely throughPost processing obtains cefoxitin acid, obtains described Cefoxitin after cefoxitin acid and sodium lactate salifySodium (I);
Course of reaction is shown below:
Initiation material cefoxitin of the present invention easily obtains, and obtains described cephalo through three stepsWestern fourth sodium, simple to operate. Wherein, the existence of the methanesulfonic acid in step (1), has improved anti-greatlyThat answers is selective, and yield and the purity of the product finally obtaining are high.
In step (1), described organic solvent is that halogenated hydrocarbon solvent is or/and alcohols solvent is preferredFor the mixed solvent of carrene and methyl alcohol, described carrene and the volume ratio of methyl alcohol are9:1～13:1, now, the yield of product is high, selectively good. Wherein, total use of described organic solventAmount, without strict especially requirement, can fully be dissolved raw material.
In step (1), as preferably, the temperature of substitution reaction is-75～-55 DEG C; As furtherPreferably, the temperature of reaction is-70～-60 DEG C; Because cephalosporin compound all has lactams four-membered ring,Can only be when temperature be lower stable existence, in the reaction system that has water to exist, the entering of hydroneAttack the four-membered ring hydrolysis that is easy to make lactams, when particularly reaction temperature is too high, cephalosporin compound is openedRing decomposes rapidly. Under the above-mentioned condition of the inventor, byproduct of reaction reduces, and product purity is high, producesThing yield is high.
In step (1), as preferably, in step (1), described cefoxitin and NBS'sThe ratio of amount of substance is 1:1.5～1:2; Described cefoxitin with the ratio of the amount of substance of sodium methoxide is1:20～1:30。
In step (1), the time of substitution reaction is 3～6h, as preferably, and the time of substitution reactionBe 3～5h.
In step (1), substitution reaction completes after the intermediate product that obtains methoxy substitution, conscientious asLower processing: add sodium sulfite in reaction system, acetic acid and saturated nacl aqueous solution stir, and 3 is littleTime after be warming up to 0 DEG C, regulating pH value with the hydrochloric acid of 2mol/L is 2, separatory, organic layer washing,Drip cyclohexylamine solution to PH6.5, add isopropyl ether, at 0 DEG C, stir 2h, separate out white crystal,Hold over night, filters, and filter cake is washed with acetone, dry, obtains 7-α-methoxyl group-7-[(2-thienyl) acetylAmino]-4-cephalosporanic acid cyclohexylamine salt.
In step (2), as preferably, hydrolysis carries out in the mixed solvent of water and methyl alcohol,The volume ratio of water and methyl alcohol is 1:1～2, now, and hydrolysis most effective.
Owing to having ester and acid amides in step (2), can in the situation that having water, be hydrolyzed hydrolysisReaction can be carried out under strong acid or highly basic catalytic condition, and the environment of reaction system is crucial, reactionSystem is under weak base or alkali condition, and reaction speed is suitable, and product yield is also considerable, therefore adoptMeet with this understanding the requirement of large production. In step (2), as preferably, described alkaline barThe pH value of part is 8～10, and this alkali condition regulates by NaOH, and alkalescence is excessively strong, can leadCause four-membered ring open loop, side reaction increases. As preferably, the temperature of described hydrolysis is 20～30 DEG C.
In step (2), the time of hydrolysis is 7～9h.
In step (2), after described hydrolysis completes, the hydrolysate obtaining carries out as followsProcess: regulate PH with acetic acid, be warming up to 25 DEG C, add ethyl acetate and acetic acid benzyl star, keep 25 DEG CStirring reaction 2h, filters, and filter cake is water successively. Ethyl acetate drip washing, the dry 3-hydroxyl first that obtains-7-α-[(2-thienyl) acetylamino]-4-cephalosporanic acid acetic acid benzyl star salt (V).
As preferably, in step (3), acylation reaction is at THF(oxolane) in carry out, thisTime, reaction yield and selectively the highest.
As preferably, in step (3), described 3-hydroxyl first-7-α-[(2-thienyl) acetylamino]-4-Ratio=the 1:1.5 of cephalosporanic acid acetic acid benzyl star salt and the amount of substance of chloro sulfonyl isocyanate, due to chlorineFor the unstability of sulfonyl isocyanate, in the time of the quantitative responses such as two kinds of reactant positions, understand some pointSeparate, the amount of participating in reaction is less than amount of calculation, and when excessive, unnecessary meeting is reacted with intermediate compound IV,Accessory substance increase causes the productive rate of target product to reduce.
As preferably, in step (3), the speed that drips described chloro sulfonyl isocyanate is 8～12d(dripping)/min(minute), reaction temperature is-65～-55 DEG C, the reaction time is 12～14 hours. ChlorineExtremely unstable for sulfonyl isocyanate solid, give out and there is penetrating odor in water in air solutionGas, drips too fast meeting too high other positions easy and reaction substrate of reaction temperature is reacted,Cause byproduct of reaction to increase, therefore its rate of addition is controlled to 8～12d/min; Temperature is to reactionThe impact of speed and productive rate, heats up reaction speed is accelerated, but productive rate is not along with the rising one of temperatureDirectly increase that more likely lactam nucleus is destroyed, accessory substance increases, and exists therefore control reaction temperature-65～-55 DEG C, product yield and purity is fine control all. The inventor screens the above by experimentCondition, and on the basis of its condition, target product productive rate and purity all obtain largelyImprove.
In step (3), described dropping chloro sulfonyl isocyanate solution, is dissolved in advancePrecooling in oxolane, is dripping, and has avoided direct dropping to produce irritating smog, and impact is thrownThe accuracy of material.
In step (3), after acylation reaction completes, be handled as follows: reactant liquor is poured in advanceIn cold distilled water, stir 2h, add ethyl acetate, by not tolerant filtration, in filtrate, add10% sodium chloride solution. Stir 10min. Separatory, organic layer is washed with 10% sodium chloride solution,Adjusting pH value with the hydrochloric acid of 2mol/L is 2.0, separates out white crystal, and hold over night is filtered filter cakeWith ethyl acetate washing, vacuum drying. Obtain cefoxitin acid. Add acetone soln, at 30 DEG C,Add sodium lactate, stir 10min, then add acetone, the vacuum drying of gained solid filtering, obtains to the endThe western fourth sodium of spore.
Compared with prior art, tool of the present invention has the following advantages:
Preparation method of the present invention, step (1) adopts NBS reagent by 7 bromines of the main core of cefoxitinChange, form brominated compound; Recycling methoxyl group is to the bromine atoms nucleophilic displacement of fluorine of 5, in the middle of producingBody IV; In step (2), 3 acyl groups that are hydrolyzed of intermediate compound IV obtain intermediate V; StepSuddenly in (3), utilize the hydrogen atom on chlorosulphonyl isocyanate substituted hydroxy, and then hydrolysis, bothObtain final products.
Organic solvent content residual in gained cefoxitin sodium product of the present invention is low, all significantlyLower than two of " Chinese pharmacopoeia " versions in 2010 to the limited amount in the regulation of residual solvent.
Preparation method's operating procedure of the present invention is simple, and cost is low, and production need not any special installation, producesYield and the purity of product are high, and the selective height (can reach 92.4%) of reaction is applicable to suitability for industrialized production.
Detailed description of the invention
Embodiment 1
7-α-methoxyl group-7-[(2-thienyl) acetylamino]-4-cephalosporanic acid cyclohexylamine salt (IV) synthetic
(1) carrene 324ml, methyl alcohol 36ml, cefoxitin 360g are added to three neck reaction bulbsIn, be cooled to-20 DEG C. Stir. Add methanesulfonic acid 10.12g, cooling, add in batches NBS(N-bromo-succinimide) (256g), adds sodium methoxide (1163g), fully stirring reaction 2h,After reacting completely, add sodium sulfite 8.24g, acetic acid 60ml, saturated nacl aqueous solution. Reaction 3After hour, be warming up to 0 DEG C, regulating pH value with the hydrochloric acid of 2mol/L is 2, separatory, and organic layer washing,Drip cyclohexylamine solution to PH6.5, add isopropyl ether, at 0 DEG C, stir 2h, separate out white crystal,Hold over night, filters, and filter cake is washed with acetone, and dry, obtaining compound IV 443.5g(yield is 97.9%,Purity is 97.6%);
Above-claimed cpd is carried out to elementary analysis, and result is as follows: C:52.53%, and H:5.95%, N:21.32%,O:7.98%, S:12.20%(is mass percent), with 7-α-methoxyl group-7-[(2-thienyl) acetylAmino] theoretical value of-4-cephalosporanic acid cyclohexylamine salt: C:52.55%, H:5.94%, N:21.31%,O:7.99.6%, S:12.2%(is mass percent) conform to.
Show that above-claimed cpd is 7-α-methoxyl group-7-[(2-thienyl) acetylamino]-4-cephalosporanic acid ringHexylamine salt.
Embodiment 2
3-hydroxyl first-7-α-[(2-thienyl) acetylamino]-4-cephalosporanic acid acetic acid benzyl star salt (IV) closesBecome
(2), by water 130.4ml, methyl alcohol 146.4ml joins in three neck reaction bulbs, cooling, addsCompound IV 410g, cooling. Slowly add the sodium hydroxide solution of the 4mol/L of precooling to adjust pH valueBe 10, be stirred well to complete reaction. Regulate PH with acetic acid, heat up and adjust PH, be warming up to 25 DEG C,Add ethyl acetate, acetic acid benzyl star 16g, keeps 25 DEG C of stirring reaction 2h. Filter, filter cake is used successivelyWater. Ethyl acetate drip washing, being dried and obtaining compound V287.11g(yield is 96%, purity is97.63%）。
Embodiment 3
Synthesizing of cefoxitin sodium (I)
(3), by compound IV 287.11g, THF joins three neck reaction bulbs, cooling, adds in batchesThe chlorosulphonyl isocyanate 158.97g of precooling, is stirred well to complete reaction. Reactant liquor is poured in advanceIn cold distilled water, stir 2h, add ethyl acetate, by not tolerant filtration, in filtrate, add10% sodium chloride solution. Stir 10min. Separatory, organic layer is washed with 10% sodium chloride solution,Adjusting pH value with the hydrochloric acid of 2mol/L is 2.0, separates out white crystal, and hold over night is filtered filter cakeWith ethyl acetate washing, vacuum drying. Obtain cefoxitin acid. Add acetone soln, at 30 DEG C,Add sodium lactate 2.0g, stir 10min, then add acetone, the vacuum drying of gained solid filtering,Be 95% to cefoxitin sodium 319.59g(yield, purity is 99.5%).
Above-claimed cpd is carried out to elementary analysis, and result is as follows: C:42.74%, and H:3.59%, N:9.36%,S:14.29%(is mass percent), with the theoretical value of cefoxitin sodium: C:42.76%, H:3.59%,N:9.35%, S:14.27%(is mass percent) conform to. Show that above-claimed cpd is CefoxitinSodium.
Comparative example 1
The first step: get 2.00 kilograms of cefoxitins, add 704 milliliters of triethylamines, 20 liters of ether;Add 1.07 kilograms of chloro sulfonyl isocyanates, stirring reaction 6 hours. Reactant liquor is cooling, then addEnter 0.5 liter of 95% ethanol, stir about 30 minutes. By reactant liquor reduced pressure concentration, add cold water, stirMix 20 minutes. Suction filtration, washing, vacuum drying, obtains faint yellow solid (being intermediate product) 1.7Kilogram, yield 85.8%.
Second step: in dry reactor, add 5 liters of absolute methanols, be cooled to-70 DEG C; Stir shapeUnder state, add 32.7 grams of lithiums, stir about 1 hour, obtain lithium methoxide solution. At another dry reactionIn device, add 1.70 kilograms of intermediate products, 15 liters of absolute ethyl alcohols, stirring and dissolving, is cooled to-70 DEG C;Add prefabricated lithium methoxide solution, insulation reaction 40 minutes, adds acetic acid, and regulating pH value is 4.0Left and right. Be warming up to room temperature, decompression and solvent recovery, residue adds cold water, has a large amount of solids to separate out.Suction filtration, washing twice, 75% recrystallizing methanol for filter cake, obtains white solid and (is CefoxitinAcid) 1.46 kilograms, yield: 85.95%.
The 3rd step: by 1.45 kilograms of cefoxitin acids, ethyl acetate 15L, drops in reactor chamberTemperature stirring and dissolving, adds activated carbon decolorizing 30min, filters, then aseptic filtration, bacteria-free filtrate is pressedEnter in desinfection chamber; By 564 grams of sodium iso-octoates, after ethyl acetate 5L stirring and dissolving, aseptic filtration,Be pressed into desinfection chamber, be placed in high-order dropwise adding tank. Sodium iso-octoate bacteria-free filtrate is slowly dropped to CefoxitinIn acid sterile liquid, agitation and dropping approximately 1.5 hours under room temperature. Dropwise slow stirring 2 hours. CrossFilter, filter cake washs with ethyl acetate, drains, and vacuum drying, obtains off-white color crystalline powder and (isCefoxitin sodium) 1.37 kilograms, yield: 94.5%.
Differentiate
HPLC differentiates
Method: get sample and cefoxitin sodium reference substance prepared by embodiment 3, use phosphate buffer(get potassium dihydrogen phosphate 1.0g and sodium hydrogen phosphate 1.8g, the 900ml that adds water dissolves, with phosphoric acid or 10mol/It is 7.1 ± 0.1 that L sodium hydroxide solution regulates pH value, is diluted with water to 1000ml) make every 1mlContaining the solution of 0.3mg, according to the high performance liquid chromatography test under assay item, test sample with contrastThe retention time of product main peak should be consistent.
Result: in the chromatogram of assay item record, the guarantor of sample main peak prepared by embodiment 3Stay the time all consistent with the retention time of the main peak of Cefoxitin reference substance, meet the requirements.
The flame reaction of sodium salt
Method: get sample prepared by embodiment 3, according to two annex III of Chinese pharmacopoeia version in 2010,The flame reaction differential method of sodium salt is tested, and should show the flame reaction of sodium salt, and result all aobvious sodium salt flame is anti-Should, meet the requirements.
Structural Identification
Embodiment 3 products obtained therefroms are carried out to Structural Identification, and method and result are as follows:
Elementary analysis
Embodiment 3 analysis results show, percentage composition and the theoretical value of CHO are basically identical.
Nuclear magnetic resoance spectrum
In mass spectral analysis cefoxitin sodium ESI-MS (m/z), quasi-molecular ion peak [M-1]+(do not comprise knotBrilliant water) be 425.5, with C in its molecular formula16H16N3NaO7S2Conform to.
The above analysis result, the chemical constitution of the sample of embodiment 3 can be confirmed as CefoxitinSodium.
Related substance
Related substance is according to the high performance liquid chromatography in two attached VD of " Chinese pharmacopoeia " version in 2010Measure:
Chromatographic condition and system suitability test: with octadecylsilane chemically bonded silica be filler; Water-Acetonitrile-glacial acetic acid (840:160:10) is mobile phase, and detection wavelength is 254nm, flow velocity 1.0ml/min,Detection wavelength is 254nm. The separating degree at cefoxitin sodium peak and other assorted peaks should conform with the regulations, theoryThe number of plates, should be lower than 2800 by cefoxitin sodium peak.
Detection method: get Cefoxitin sodium sample prepared by embodiment 3 and comparative example 1, add respectively phosphate(get potassium dihydrogen phosphate 1.0g and sodium hydrogen phosphate 1.8g, the 900ml that adds water dissolves buffer solution, uses phosphorusIt is 7.1 ± 0.1 that acid or 10mol/L caustic lye of soda regulate pH value, is diluted with water to 1000ml, mixedEven, filter and get final product) make the solution that every 1ml approximately contains Cefoxitin 0.3mg, as need testing solution;Get need testing solution 20 μ l injection liquid chromatographies, record chromatogram to 2 of principal component peak retention timeDoubly. By normalization method calculate each impurity peak area and, must not be greater than 2% of total peak area, andLarge impurity peaks must not be greater than 1% of total peak area.
Result is as follows: in Cefoxitin sodium sample prepared by embodiment 3 and comparative example 1, related substance dividesBe not 0.12%, 0.18%, 0.14%, the single impurity peak area of 3.2%(is with respect to the master of contrast solutionThe percentage of peak area); Measurement result shows: single in the chromatogram of cefoxitin sodium highly finished product solutionIndividual impurity peak area is less than the main peak area (1.0%) of contrast solution, meets the requirements.
Claims (1)
1. a preparation method for cefoxitin sodium, is characterized in that, step is as follows:
(1) by carrene 324ml, methyl alcohol 36ml, cefoxitin 360g adds in three neck reaction bulbs, be cooled to-20 DEG C, stir, add methanesulfonic acid 10.12g, cooling, add in batches NBS256g, add sodium methoxide 1163g, fully stirring reaction 2h, after reacting completely, add sodium sulfite 8.24g, acetic acid 60ml, saturated nacl aqueous solution, react and be warming up to 0 DEG C after 3 hours, with the salt acid for adjusting pH value of 2mol/L be 2, separatory, organic layer washing, drip cyclohexylamine solution to pH6.5, add isopropyl ether, at 0 DEG C, stir 2h, separate out white crystal, hold over night, filter, filter cake is washed with acetone, dry, obtain 7-α-methoxyl group-7-[(2-thienyl) acetylamino]-4-cephalosporanic acid cyclohexylamine salt 443.5g, yield is 97.9%, purity is 97.6%,
(2) by water 130.4ml, methyl alcohol 146.4ml joins in three neck reaction bulbs, cooling, add 7-α-methoxyl group-7-[(2-thienyl) acetylamino]-4-cephalosporanic acid cyclohexylamine salt 410g, cooling, the sodium hydroxide solution adjust pH that slowly adds the 4mol/L of precooling is 10, be stirred well to complete reaction, use second acid for adjusting pH, heat up and adjust pH, be warming up to 25 DEG C, add ethyl acetate, acetic acid benzyl star 16g, keep 25 DEG C of stirring reaction 2h, filter, filter cake is water successively, ethyl acetate drip washing, dry 3-hydroxyl first-7-α-[(2-thienyl) acetylamino]-4-cephalosporanic acid acetic acid benzyl star salt 287.11g that obtains, yield is 96%, purity is 97.63%,
(3) by 3-hydroxyl first-7-α-[(2-thienyl) acetylamino]-4-cephalosporanic acid acetic acid benzyl star salt 287.11g, THF joins three neck reaction bulbs, cooling, add the chlorosulphonyl isocyanate 158.97g of precooling in batches, be stirred well to complete reaction, reactant liquor is poured in the distilled water of precooling, stir 2h, add ethyl acetate, by not tolerant filtration, in filtrate, add 10% sodium chloride solution, stir 10min, separatory, organic layer is washed with 10% sodium chloride solution, with the hydrochloric acid adjust pH of 2mol/L be 2.0, separate out white crystal, hold over night, filter, filter cake washs with ethyl acetate, vacuum drying, obtain cefoxitin acid, add acetone soln, at 30 DEG C, add sodium lactate 2.0g, stir 10min, add again acetone, the vacuum drying of gained solid filtering, obtain cefoxitin sodium 319.59g, yield is 95%, purity is 99.5%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310369951.1A CN103450225B (en) | 2013-08-22 | 2013-08-22 | The preparation method of cefoxitin sodium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310369951.1A CN103450225B (en) | 2013-08-22 | 2013-08-22 | The preparation method of cefoxitin sodium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103450225A CN103450225A (en) | 2013-12-18 |
| CN103450225B true CN103450225B (en) | 2016-05-04 |
Family
ID=49733107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310369951.1A Active CN103450225B (en) | 2013-08-22 | 2013-08-22 | The preparation method of cefoxitin sodium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103450225B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104072521A (en) * | 2014-06-27 | 2014-10-01 | 广东省石油化工研究院 | Preparation method for cefoxitin acid |
| CN104402908B (en) * | 2014-10-23 | 2017-10-27 | 胡梨芳 | Cefoxitin sodium compound entity and combinations thereof and purposes |
| CN104402909B (en) * | 2014-11-12 | 2017-03-15 | 盐城开元医药化工有限公司 | A kind of synthetic method of cefoxitin acid |
| CN104447800B (en) * | 2014-11-21 | 2016-11-16 | 辽宁天华生物药业有限公司 | A kind of synthetic technology of cefoxitin acid |
| CN104890950A (en) * | 2015-04-27 | 2015-09-09 | 四川制药制剂有限公司 | Injection cefoxitin sodium preparation technology for automatically examining products |
| CN106995453B (en) * | 2017-04-01 | 2019-05-03 | 齐鲁安替制药有限公司 | The crystallization and preparation method thereof of 7 α of cephalosporin intermediate-methoxyl group cefoxitin |
| CN110396105B (en) * | 2018-09-10 | 2021-03-19 | 广东金城金素制药有限公司 | Application of Mefliximab Cefoxitin Sodium in Prevention of Infection in Gastrointestinal Surgery |
| CN109651403B (en) * | 2018-12-29 | 2022-01-07 | 上海上药新亚药业有限公司 | Synthesis method of cefoxitin sodium |
| CN110396102B (en) * | 2019-01-15 | 2021-05-04 | 广东金城金素制药有限公司 | Cefoxitin sodium compound pharmaceutical preparation and its application in preventing infection before vaginal hysterectomy, abdominal hysterectomy and cesarean (uterine) operation |
| CN119192277A (en) * | 2023-06-27 | 2024-12-27 | 苏州盛达药业有限公司 | A preparation method of cefoxitin derivatives |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101007812A (en) * | 2007-01-26 | 2007-08-01 | 深圳信立泰药业有限公司 | Antibacterial drugs cefoxitin preparation process |
| CN101235045A (en) * | 2008-02-26 | 2008-08-06 | 芦红代 | Method for preparing cefoxitin sodium |
| CN102153567A (en) * | 2010-05-28 | 2011-08-17 | 重庆天地药业有限责任公司 | Method for preparing cefoxitin acid |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004083217A1 (en) * | 2003-03-20 | 2004-09-30 | Orchid Chemicals & Pharmaceuticals Ltd | An improved process for the preparation of cefoxitin |
-
2013
- 2013-08-22 CN CN201310369951.1A patent/CN103450225B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101007812A (en) * | 2007-01-26 | 2007-08-01 | 深圳信立泰药业有限公司 | Antibacterial drugs cefoxitin preparation process |
| CN101235045A (en) * | 2008-02-26 | 2008-08-06 | 芦红代 | Method for preparing cefoxitin sodium |
| CN102153567A (en) * | 2010-05-28 | 2011-08-17 | 重庆天地药业有限责任公司 | Method for preparing cefoxitin acid |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103450225A (en) | 2013-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103450225B (en) | The preparation method of cefoxitin sodium | |
| CN101307015B (en) | Process for preparing cilastatin sodium | |
| CN101235045A (en) | Method for preparing cefoxitin sodium | |
| CN107501265B (en) | A kind of 7- oxo-diazabicylo [3,2,1] octane derivatives compound and its preparation method and application | |
| CN101619069A (en) | Preparation method of cefotiam hexetil hydrochloride | |
| CN107325082B (en) | Preparation method of high-purity afatinib | |
| CN104710486A (en) | Method for synthesizing SGLT2 inhibitor drugs | |
| CN102675306A (en) | Preparing method of moxifloxacin or slat thereof | |
| CN101787036B (en) | High-purity cefamandole sodium compound | |
| CN104402909B (en) | A kind of synthetic method of cefoxitin acid | |
| CN111825678A (en) | Preparation method of carbamatinib | |
| CN110183445A (en) | The synthetic method of Moxifloxacin and its derivative | |
| CN101857601B (en) | Latamoxef sodium compound with high purity | |
| CN106188097B (en) | A kind of preparation method of 3 chloromethyl oxacephems antibiotic parent nucleus | |
| CN104072516A (en) | Method for synthesizing cefuroxime acid | |
| CN109134331B (en) | Synthesis method of azithromycin genotoxic impurity | |
| CN106279207A (en) | A kind of synthetic method of cefdinir | |
| CN103664948B (en) | Crystallization of a kind of intermediate of L-084 and preparation method thereof | |
| CN101735244A (en) | Method for preparing broad-spectrum penicillin antibiotic ticarcillin sodium | |
| CN104230956B (en) | A kind of preparation method of cefoxitin | |
| CN105017287B (en) | A kind of preparation method of cephamycin intermediate | |
| CN110183446B (en) | A kind of moxifloxacin new impurity and its synthetic method and use | |
| CN106366097A (en) | Preparation method of cefditoren pivoxil | |
| CN101735296B (en) | Method for preparing fludarabine | |
| CN102127034B (en) | Preparation method of cefozopran side chain acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| CB02 | Change of applicant information |
Address after: 570216, East B District, No. 6, Haikou Free Trade Zone, No. 168 Nanhai Road, Hainan, Haikou Applicant after: HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD. Address before: 570216, East B District, No. 6, Haikou Free Trade Zone, No. 168 Nanhai Road, Hainan, Haikou Applicant before: Hainan Gourd Doll Pharmaceutical Co., Ltd. |
|
| COR | Change of bibliographic data | ||
| GR01 | Patent grant |